在免疫激活癌症中,TAK1抑制会导致RIPK1依赖的亡
Helene Damhofer1,2,3, Tülin Tatar1,3, Benjamin Southgate4
1Division of Cancer Biology, The Institute of Cancer Research, London, UK.
Cell death & disease
|April 17, 2024
概括
向TGFβ激活激酶 (TAK1) 提供了通过诱导质瘤干细胞 (GSCs) 中的亡来治疗质母细胞 (GBM) 的新疗法策略. 这种方法对免疫激活的癌症,包括介质性GBM,有前途.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症干细胞生物学
背景情况:
- 质母细胞瘤 (GBM) 的存活率很低,治疗反应有限,主要是由于持续性质母细胞 (GSCs).
- 在GSC中确定新的治疗点对于改善GBM患者的治疗结果至关重要.
研究的目的:
- 在质母细胞干细胞中确定新的治疗点.
- 研究TGFβ激活激酶 (TAK1) 作为GSC中生存因子的作用.
- 探索针对GBM中的TAK1的治疗策略.
主要方法:
- 使用CRISPR/Cas9淘汰屏幕来确定GSC的生存因素.
- 研究了TAK1损失诱导的亡机制,包括RIPK1,Caspase-8,FADD,TNFα和TNFR信号传递.
- 确定了一种转录特征,用于预测对TAK1抑制的敏感性.
- 评估了促炎性细胞因子 (IFNγ,TNFα) 对 GSC 对 TAK1 抑制的敏感性的影响.
主要成果:
- TGFβ激活激酶 (TAK1) 被确定为GSCs的一个子集的选择性生存因子.
- 失去了TAK1激酶的活性触发RIPK1-依赖的亡通过卡斯巴-8/FADD激活,由特异性TNFα和TNFR信号传递的介导.
- 与免疫激活和介质性GBM亚型相关的特定转录特征预测了对TAK1抑制的敏感性.
- 支持炎症的细胞因子IFNγ和TNFα可以使抵抗TAK1抑制的GSCs敏感.
结论:
- 在免疫激活癌症中,TAK1激酶活性是一个新的脆弱性,特别是介质性GBM.
- 向TAK1代表了质母细胞瘤的一个有前途的治疗策略.
- 识别的转录特征可以预测对像HS-276.6这样的TAK1抑制剂的治疗反应.
相关概念视频
01:31The Intrinsic Apoptotic Pathway
6.5K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K
01:17The Extrinsic Apoptotic Pathway
6.3K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.3K
01:20The JAK-STAT Signaling Pathway
8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.8K
01:22PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:31Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K